These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 11877331)

  • 41. Potentiation of ligand binding through cooperative effects in monoamine oxidase B.
    Bonivento D; Milczek EM; McDonald GR; Binda C; Holt A; Edmondson DE; Mattevi A
    J Biol Chem; 2010 Nov; 285(47):36849-56. PubMed ID: 20855894
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of central monoamine oxidase by imidazoline2 site-selective ligands.
    Lalies MD; Hibell A; Hudson AL; Nutt DJ
    Ann N Y Acad Sci; 1999 Jun; 881():114-7. PubMed ID: 10415906
    [No Abstract]   [Full Text] [Related]  

  • 43. Biosensor based on inhibition of monoamine oxidases A and B for detection of β-carbolines.
    Radulescu MC; Bucur MP; Bucur B; Radu GL
    Talanta; 2015 May; 137():94-9. PubMed ID: 25770611
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relationship between imidazoline/guanidinium receptive sites and monoamine oxidase A and B.
    Raddatz R; Lanier SM
    Neurochem Int; 1997 Jan; 30(1):109-17. PubMed ID: 9116581
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of the imidazoline binding site involved in regulation of insulin secretion.
    Morgan NG; Chan SL; Brown CA; Tsoli E
    Ann N Y Acad Sci; 1995 Jul; 763():361-73. PubMed ID: 7677348
    [No Abstract]   [Full Text] [Related]  

  • 46. The imidazoline receptor ligand 2-(2-benzofuranyl)-2-imidazoline is a dopamine-releasing agent in the rat striatum in vivo.
    Sastre-Coll A; Esteban S; Miralles A; Zanetti R; García-Sevilla JA
    Neurosci Lett; 2001 Mar; 301(1):29-32. PubMed ID: 11239709
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Binding of the imidazoline ligand 3H-2-benzofuranyl-2-imidazoline (BFI) to human brain and platelets. Potentiation by tranylcypromine and role of MAO isoforms.
    Steinberg MI; Wiest SA; Pickard RT; Chen K; Shih JC
    Ann N Y Acad Sci; 1999 Jun; 881():193-8. PubMed ID: 10415915
    [No Abstract]   [Full Text] [Related]  

  • 48. Pharmacologic and molecular discrimination of I2-imidazoline receptor subtypes.
    Olmos G; Alemany R; Boronat MA; García-Sevilla JA
    Ann N Y Acad Sci; 1999 Jun; 881():144-60. PubMed ID: 10415910
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metabolism of agmatine (clonidine-displacing substance) by diamine oxidase and the possible implications for studies of imidazoline receptors.
    Holt A; Baker GB
    Prog Brain Res; 1995; 106():187-97. PubMed ID: 8584654
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Attenuation of acute and chronic effects of morphine by the imidazoline receptor ligand 2-(2-benzofuranyl)-2-imidazoline in rat locus coeruleus neurons.
    Ruiz-Durántez E; Torrecilla M; Pineda J; Ugedo L
    Br J Pharmacol; 2003 Feb; 138(3):494-500. PubMed ID: 12569074
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Imidazoline-binding domains on monoamine oxidase B and subpopulations of enzyme.
    Raddatz R; Savic SL; Bakthavachalam V; Lesnick J; Jasper JR; McGrath CR; Parini A; Lanier SM
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1135-45. PubMed ID: 10688633
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Imidazoline/guanidinium binding domains on monoamine oxidases. Relationship to subtypes of imidazoline-binding proteins and tissue-specific interaction of imidazoline ligands with monoamine oxidase B.
    Raddatz R; Parini A; Lanier SM
    J Biol Chem; 1995 Nov; 270(46):27961-8. PubMed ID: 7499273
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increase of beta-endorphin secretion by agmatine is induced by activation of imidazoline I(2A) receptors in adrenal gland of rats.
    Chang CH; Wu HT; Cheng KC; Lin HJ; Cheng JT
    Neurosci Lett; 2010 Jan; 468(3):297-9. PubMed ID: 19913596
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro and in vivo effect of BU99006 (5-isothiocyanato-2-benzofuranyl-2-imidazoline) on I2 binding in relation to MAO: evidence for two distinct I2 binding sites.
    Paterson LM; Tyacke RJ; Robinson ES; Nutt DJ; Hudson AL
    Neuropharmacology; 2007 Feb; 52(2):395-404. PubMed ID: 17045310
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro and ex vivo distribution of [3H]harmane, an endogenous beta-carboline, in rat brain.
    Anderson NJ; Tyacke RJ; Husbands SM; Nutt DJ; Hudson AL; Robinson ES
    Neuropharmacology; 2006 Mar; 50(3):269-76. PubMed ID: 16242163
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Agmatine--an endogenous ligand of imidazoline receptors].
    Kozaeva LP; Korobov NV
    Eksp Klin Farmakol; 2003; 66(5):69-73. PubMed ID: 14650220
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Endogenous imidazoline receptor ligands relax rat aorta by an endothelium-dependent mechanism.
    Musgrave IF; Van Der Zypp A; Grigg M; Barrow CJ
    Ann N Y Acad Sci; 2003 Dec; 1009():222-7. PubMed ID: 15028591
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vivo estimation of imidazoline(2) binding site turnover.
    Paterson LM; Robinson ES; Nutt DJ; Hudson AL
    Ann N Y Acad Sci; 2003 Dec; 1009():367-70. PubMed ID: 15028614
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Agmatine--a novel endogenous ligand of imidazoline receptors.
    Herman ZS
    Pol J Pharmacol; 1997; 49(2-3):85-8. PubMed ID: 9437754
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The imidazoline I
    Siemian JN; Woodhouse K; Liu DH; Zhang Y; Li JX
    Psychopharmacology (Berl); 2024 Mar; 241(3):479-487. PubMed ID: 38159161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.